Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07484009Not ApplicableRecruiting

ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure

Role: collaborator

NCT07240038Recruiting

Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)

Role: collaborator

NCT06956729Not ApplicableRecruiting

Multicenter Trial of Proximal Femoral Guided Growth in Children With CP and Hips at Risk of Dislocation (GGSH-MC)

Role: collaborator

NCT03850756Completed

Early Diagnosis of Kidney Damage Associated With Tobacco Use

Role: collaborator

NCT04225013Completed

Early Diagnosis as Strategy in Reducing the Incidence of Contrast-induced Nephropathy

Role: collaborator

NCT06506071Recruiting

Characterization of Acute Myocardial Damage With Spectral Computed Tomography. (CADAMI-SPECTRAL)

Role: lead

NCT04413071Completed

Cardiac COVID-19 Health Care Workers

Role: collaborator

All 7 trials loaded